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Abstract 
Despite a growing number of reports, there is still limited knowledge of the clinical features that 
precede the onset of bipolar disorder (BD). To explore this, we investigated baseline data from a 
prospectively evaluated longitudinal cohort of subjects aged 12-30 years to compare: first, lifetime 
rates of clinical features between a) subjects at increased genetic risk for developing BD (‘AR’), b) 
participants from families without mental illness (‘controls’), and c) those with established BD; and, 
second, prior clinical features that predict the later onset of affective disorders in these same three 
groups. This is the first study to report such comparisons between these three groups (though 
certainly not the first to compare AR and control samples). 118 AR participants with a parent or 
sibling with BD (including 102 with a BD parent), 110 controls, and 44 BD subjects were assessed 
using semi-structured interviews. AR subjects had significantly increased lifetime risks for depressive, 
anxiety and behavioural disorders compared to controls.   Unlike prior reports, preceding anxiety 
and behavioural disorders were not found to increase risk for later onset of affective disorders in the 
AR sample, perhaps due to limited sample size. However, preceding behavioural disorders did 
predict later onset of affective disorders in the BD sample. The findings that i) AR subjects had higher 
rates of depressive, anxiety and behavioural disorders compared to controls, and ii) prior 
behavioural disorders increased the risk to later development of affective disorders in the BD group, 
suggest the possibility of therapeutic targeting for these disorders in those at high genetic risk for 
BD.  
Keywords: bipolar disorder, genetic, psychopathology, adolescent, at risk, high risk 
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  Introduction 
There is a growing interest in identifying the earliest stages of bipolar disorder (BD) (Berk et al., 
2014; Scott et al., 2013) so as to ultimately enable the capacity for developing early intervention 
programs for this condition (Mitchell et al., 2013a). As BD is a strongly genetic disorder (McGuffin et 
al., 2003; Mortensen et al., 2003) which usually presents in late adolescence or the early twenties 
(Merikangas et al., 2007), prospective longitudinal studies of cohorts at high genetic risk provide the 
potential means for identifying early features of this condition, in terms of both baseline differences 
compared to controls and, moreover, those features that are predictive of the later development of 
mania or hypomania.  
There has been a growing but still relatively small number of reports of such high-risk BD 
studies, both cross-sectional and longitudinal. A recent major example which epitomises the 
expected rates of “conversion” to BD in such cohorts came from the Dutch high risk bipolar cohort 
(Mesman et al., 2013). That paper reported 13% of the offspring of parents with bipolar I or II 
disorders developing some form of BD spectrum by the 12-year follow-up. 
The striking finding - from both the longitudinal reports and cross-sectional studies 
comparing high risk groups to controls – is the high rate and broad range of psychopathology 
reported in this population. The prospective Dutch study (Mesman et al., 2013) reported that by 12 
years, 72% had developed at least one lifetime DSM-IV disorder. Fifty-four percent had experienced 
some mood disorder (mainly depression), 27% an anxiety disorder, 25% a substance use disorder 
(SUD), and 8% a disruptive behavioural disorder. Similarly, cross-sectional comparisons of 
populations of high-risk young people have also reported a greater prevalence of lifetime non-
affective psychiatric diagnoses such as anxiety, disruptive behavioural disorders and SUDs when 
compared to control and major depressive disorder samples (Birmaher et al., 2009; Duffy et al., 
2014; Hillegers et al., 2005; Leopold et al., 2014; Nurnberger et al., 2011; Shaw et al., 2005; 
Vandeleur et al., 2012; Wals et al., 2001; Whalley et al., 2011).  
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Another issue arising from recent studies is whether the risk to developing later depression 
or BD in these high risk families is increased by the prior occurrence of non-affective conditions. Two 
groups have reported that the prior onset of anxiety disorders, behavioural disorders and SUDs 
increase the risk for developing later affective disorders (Duffy et al., 2007; Duffy et al., 2010; Duffy 
et al., 2014; Nurnberger et al., 2011).   
Most studies of BD high-risk subjects have compared findings against control subjects with 
no family history of severe mental illness. However, also comparing those at high-risk to those with 
established BD may provide complementary information on both the prior developmental trajectory 
and comorbid characteristics of the condition. To date, there has only been one such study 
(Goldstein et al., 2010) which compared rates of lifetime comorbid disorders in high-risk offspring 
without BD against high-risk offspring with BD. It demonstrated that those with BD have higher 
lifetime rates of anxiety disorders, oppositional defiant disorder or conduct disorder, and ADHD 
compared to those without BD.   
This current study is novel in comparing rates and ages of onset of a range of psychiatric 
disorders between three groups: i) those genetically at-risk for developing BD who have not yet 
developed this condition (i.e. those with a first-degree relative with the disorder) – the ‘AR’ group; ii) 
those with no family of significant psychiatric history - ‘controls’; and iii) those with established BD 
(with or without a family history of BD) – the ‘BD’ group. All subjects were within the age range of 
12-30 years. As detailed above, there have been a number of prior studies which have compared AR 
and control samples.  
The focus of this study was on clarifying the clinical features that precede the onset of 
bipolar disorder. We hypothesised that: i) AR subjects would have higher lifetime rates of 
depressive, anxiety and behavioural disorders compared to controls; and ii) within the AR and BD 
cohorts, onset of anxiety and behavioural disorders would precede the onset of their first major 
mood episode.  
Method 
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The study was conducted with the approval of the University of New South Wales Human Research 
Ethics Committee (HREC Protocol 09/104) and the South Eastern Sydney Illawarra Health Service 
HREC (Protocol 09/097) in Sydney, Australia. Written informed consent from all participants was 
obtained and additional parental consent was obtained for participants under the age of 16. 
Recruited participants are involved in an ongoing longitudinal study with annual follow-up 
evaluations. The clinical protocol for those aged between 12 and 21 years of age was identical to 
that for a NIMH-funded collaborative prospective study of an at-risk cohort (Nurnberger et al., 
2011), but there was no overlap between the sample described in this paper, and that of Nurnberger 
et al (2011). 
Ascertainment and assessments 
AR and BD participants were recruited from: families who had previously participated in a BD 
pedigree molecular genetics study or a specialised BD research clinic; clinicians; mental health 
consumer organisations; publicity through print and electronic media; and noticeboards in 
universities and local communities. (The majority of AR and BD subjects were recruited via print and 
electronic media publicity). Control subjects were recruited from print and electronic media, and 
noticeboards in universities and local communities.   
AR subjects were defined as first degree relatives - children or siblings - of a proband with a 
confirmed DSM-IV-TR diagnosis of BD I or II. As confidence in the validity of the proband BD 
diagnosis was critical to this study, only those AR subjects with confirmed proband consensus best-
estimate BD diagnoses based on the Diagnostic Interview for Genetic Studies (DIGS v. 4, Nurnberger 
et al., 1994), the Family Interview for Genetic Studies (FIGS, (Maxwell, 1992)) and medical records 
(where available) were included.  
Controls were defined as those without a parent or sibling with BD I or II, recurrent major 
depression (MDD), schizoaffective disorder, schizophrenia, recurrent substance abuse or any past 
psychiatric hospitalisation; and those who did not have a second degree relative who had a past 
mood disorder hospitalisation or history of psychosis. 
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AR and control participants with a lifetime or current presence of psychiatric symptoms 
(apart from the occurrence of BD) were not excluded from the study; this ecological approach has 
been used by similar studies of individuals at high genetic risk for BD (Nurnberger et al, 2011).   
All potentially interested subjects underwent an initial screening process which involved a 
brief family history of psychiatric diagnoses and general information about affected relatives. The 
Family Interview for Genetic Studies (FIGS) (Maxwell, 1992) was administered to all participants at 
baseline entry to determine any family history of affective disorders. For those aged between 12 and 
21 (in all three groups), at least one parent had to be available to complete the FIGS and the Kiddie-
Schedule for Affective Disorders and Schizophrenia for School-Aged Children – Present and Lifetime 
Version (K-SADS-BP) (Kaufman et al., 1997; Nurnberger et al., 2011) about their participating child. 
The K-SADS-BP was administered to both the parent and child; ratings from both the parent and 
child were then used to determine summary ratings for each symptom. The Diagnostic Interview for 
Genetic Studies, DIGS v. 4 (Nurnberger et al., 1994), was administered to all participants aged 
between 22 and 30, and the BD proband (parent or sibling) of all AR participants to confirm proband 
diagnosis. Similarly, parents of the control participants completed the DIGS to confirm eligibility into 
the study.  
All clinical interviewers possessed at least an honours degree in psychology with some 
possessing postgraduate degrees in psychology-related fields. Interviewers were extensively trained 
by a clinical research manager from one of the collaborating US sites, the principal investigator and 
the study coordinator.  
Diagnostic procedure 
Using the Best Estimate Methodology (Leckman et al., 1982), lifetime diagnoses and age of onset 
were determined by the consensus of two independent raters (psychiatrists) who were blind to the 
family status of participants. This approach combined information from the DIGS or the K-SADS-BP, 
the FIGS, and medical records (where available) in order to determine whether the participant met 
diagnostic criteria for a lifetime DSM-IV-TR diagnosis and its age of onset. For each diagnosis, the 
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independent raters rated their diagnostic confidence based on a 4-point scale [1= diagnosis asserted 
without supporting symptoms; 2 possible; some criteria met (both informants) or all criteria met 
(one informant) with some supporting information; 3= probably; all criteria met, no supporting 
documentation; 4= definite; meets criteria and has supporting documentation]. For this paper, only 
diagnoses achieving a confidence level of 3 or 4 were considered.  
Data Analysis 
Between groups analyses of demographic and clinical characteristics between AR (with separate 
analyses for i) those with either parent or sibling probands, and ii) only those with a parent 
proband), control and BD groups were performed using ANOVA (Welch’s statistic), chi-square and 
Fisher’s exact tests (FETs) where appropriate. Generalized linear mixed models (GLMM) were then 
used to compare clinical characteristics between groups while adjusting for demographic variables 
(gender, age and ethnicity) and parental factors (parental status and parental diagnoses). GLMM is a 
subject-specific method which accounts for within-sample clustering, for example, families with 
more than one participating member.  To investigate onset of various disorder we carried out 
survival analyses. Hazards for onset were modelled in a discrete-time framework using a 
complementary log-log link. Due to some difficulties in obtaining estimates using GLMM, we 
switched to generalized linear models using generalized estimating equations (GEE), a marginal 
method which corrects for within-sample correlations.  The survival analyses investigated 
differences between groups (AR, control and BD) in the onset of major affective disorders (BD I; BD 
II; MDD; single major depressive episode), anxiety disorders (OCD; panic with and without 
agoraphobia; social phobia; specific phobia; GAD; agoraphobia), behavioural disorders (ADHD, 
inattentive type; DHD, hyperactivity-impulsivity; conduct disorder; antisocial personality disorder; 
oppositional defiant disorder), and SUDs (abuse or dependence of: alcohol; nicotine; cannabis; 
cocaine; sedative; stimulant; opiate; other substance) respectively. Apart from subjects’ status (i.e., 
AR, control or BD) the only other covariates in these models were years-of-age (linear trend plus 
quadratic and cubic where feasible) and gender. The estimates from these models were used to 
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form survival curves (modelled, not observed) illustrating the differences between groups in the 
onset of disorders.  GEE was also used in subsequent within group analyses to determine the 
prognostic significance of the prior onset of anxiety disorder, behavioural disorder, and SUD on the 
onset of affective disorders.  
Results 
Participants 
The AR sample comprised 118 participants; 72 were aged between 12 and 21 years old, and 46 were 
aged between 22 and 30 years old. For 87 AR subjects, the proband had BD I; and for 31, BD II. For 
97 AR subjects, the proband was a parent; for 16 the proband was a sibling; and for 5, there was 
both a parent and a sibling with BD (in this case the parent was considered the primary proband).  
The sample was comprised of 70 families where the proband was a parent (45 families with a single 
participating offspring, 18 families with 2 participating offspring and 7 families with 3 or more 
participating offspring), 15 families where the proband was a sibling (14 families with a single 
participating sibling, 1 family with 2 active siblings and none with 3 siblings or more siblings), and 3 
families where there was a parent and a sibling with bipolar disorder (1 family with a single 
participating family member, 2 families with 2 participating family members).  
The control sample consisted of 110 participants. Forty-five controls were aged between 12 
and 21 years, and 65 were aged between 22 and 30 years. The younger control sample (12-21 years-
old) included one family which had two participating siblings.  None of the older control participants 
(aged 22-30 years old) had siblings in this study.   
The BD sample was comprised of 44 participants with a confirmed DSM-IV-TR diagnosis of 
BD I (n=27), BD II with recurrent depressive episodes (n=15), and BD II with a single depressive 
episode (n=2).  No participants in the BD sample met criteria for a current episode of either 
depression or hypo/mania.  Ten of the BD participants also had a first-degree relative with a 
confirmed diagnosis of BD I (n=7) or II (n=3). Ten BD participants were aged between 12 and 21 years 
of age, and 34 were aged between 22 and 30 years.   
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Comparisons between AR, control and BD samples 
First, considering the AR sample with either parent or sibling probands, there were significant 
differences between the three groups in terms of age, ethnicity, years of education, occupation and 
home environment (Table 1) which were therefore controlled for in subsequent analyses. Control 
subjects (M=22.5 years) were older than the AR group (M=19.9), while in turn, the BD individuals 
(M=24) were older than the control and AR samples (Welch F (2,269) =15.66, p<.0001). There were 
significant differences in the proportions of those with Caucasian ethnicity between the groups, with 
99.2% in the AR group, 86.4% in the BD sample and 69.1% amongst controls (χ
2
=40.27, p<.0001). The 
BD sample contained a significantly greater number of people who were either not employed or not 
a student (20.5%) when compared to the controls and AR subjects (χ
2
=18.59, p<.01). Over half of 
those in the AR and BD groups lived with at least one biological parent or relative compared to 
35.5% of controls (χ
2
=19.91, p<.01).  
[INSERT TABLE 1 ABOUT HERE] 
With regard to family history, 86.4% of the AR sample had one parent with BD, with 69% of 
these parents having BD I. The remaining 13.6% only had a sibling with BD. In the BD sample, 22.7% 
(n=10) had one parent with BD with 70% (n=7) of these parents having BD I. 24.6% of the AR and 
43.2% of BD subjects had at least one parent with MDD. 15.3% of the at-risk subjects and 18.2% of 
those with BD had at least one parent with an anxiety disorder. None of the parents of the BD group 
had a diagnosis of ADHD and only one parent of an at-risk subject had a diagnosis of ADHD. Only one 
parent of a BD individual had experienced psychosis while none of the at-risk parents met such 
criteria. None of the control parents met criteria for a lifetime diagnosis of an anxiety disorder, 
ADHD or psychosis.  
When considering the AR group with only parent probands (n=102), the levels of significance 
for comparisons for both demographic and family history characteristics were the same as for those 
detailed in the prior two paragraphs for the AR group with parent or sibling probands. 
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The distribution of lifetime diagnoses and differences between the three groups (considering 
the AR group with either parent or sibling probands) is presented in Table 2, along with details on 
age of onset.   29.7% of the AR group were diagnosed as having a depressive disorder (MDD or a 
single major depressive episode) at some stage of their life compared to 12.7% of controls (FET; 
p<.0001). There were differences in rates of anxiety disorders across the three groups, with 22.9% of 
AR subjects and 52.3% of the BD sample meeting criteria for an anxiety disorder compared to 10% of 
controls (χ
2
=32.31, p<.0001). With respect to behavioural disorders, there were significant 
differences between both the AR and control groups (FET; p<.001) and the BD and control groups 
(FET; p<.0001). There were no significant differences between control and AR subjects in the rates of 
SUDs but there was a significantly higher proportion of individuals in the BD group (29.5%) who had 
a SUD (χ
2
=22.71, p<.0001). With regard to lifetime rates of psychiatric disorders, 5.5% of controls 
had two or more lifetime diagnoses compared to 17.8% of the AR group, and 65.9% of those with BD 
(p<.0001).  
When considering the AR group with only parent probands, the levels of significance for 
comparisons for rates of lifetime diagnoses were the same as for those detailed in the prior 
paragraph for the AR group with parent or sibling probands. 
[INSERT TABLE 2 ABOUT HERE] 
Table 3 presents the adjusted odds ratios (ORs) derived from mixed models. With 
adjustment for the individual’s gender, age, ethnicity and home environment (the current parental 
relationship status), the models supported results found in the between-group univariate analyses. 
These models demonstrated that being in the AR group (here firstly considering those with either 
parental or sibling probands) when compared to controls was associated with an increased risk for a 
depressive disorder (OR=2.6, 95% CI: 1.2-5.8, p<.05), any anxiety disorder (OR=2.7, 95% CI: 1.2-6.2, 
p<.05), a behavioural disorder (OR 3.9, 95% CI: 0.9-17.0, p = 0.07) and having at least two lifetime 
diagnoses (OR=3.2, 95% CI: 1.2-8.5, p<.05). The BD group showed greater associated risks for any 
anxiety disorder (OR=9.7, 95% CI: 3.9-24.2, p<.0001), any behavioural disorder (OR=7.9, 95% CI: 1.8-
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35.0, p<.01), any SUD (OR=6.2, 95% CI: 2.1-18.3, p<.01) and having at least two lifetime diagnoses 
(OR=27.8, 95% CI: 9.7-79.8, p<.001) compared to controls.  Analyses were conducted on for only 
those diagnosed with BD who had a family history of BD (n=27) and similar results were obtained.  
When considering the AR group with only parent probands, there were a few differences in 
the significance levels of some of the comparisons compared to controls, though minimal differences 
in the odds ratios, suggesting a possible reduction in statistical power with reduced sample size. For 
anxiety disorders there was now only a trend towards statistical significance (OR=2.3, 95% CI: 1.0-
5.5, p=0.07) while the comparison for behavioural disorders was no longer significant (OR 3.5, 95% 
CI: 0.8-16.0, p = NS). 
[INSERT TABLE 3 ABOUT HERE] 
Chi-square analyses did not show significant between-group differences in the number of 
participants currently from single-parent homes, and homes where both biological parents were 
present respectively. However, multilevel mixed models revealed that, on combining all groups 
(control, AR and BD), the odds of having an affective disorder (depression or BD) was 4.9 times 
greater for those living within a single biological parent home than for those living with both 
biological parents (OR=4.9, 95% CI: 1.4-16.7, p<.001). There was insufficient power to determine 
interaction effects between groups and the home environment.   
 For AR individuals, there were no differences in the rates of disorders between those whose 
BD proband was a parent or a sibling. Similarly, there were no differences in the rates of disorders 
between AR subjects with probands with BD I or II. Further analyses showed that other parental 
disorders - i.e. anxiety and substance use disorders - were not associated with an increased risk for 
any psychiatric disorders within the AR sample.  
Survival and hazard analyses 
Figure 1 (A) demonstrates a significant difference between all AR and control subjects (HR= 
3.49, 95% CI: 1.86–6.55, p<.0001), and between BD and control subjects (HR= 21.91, 95% CI: 12.24–
39.21, p<.0001) in the onset of any lifetime affective disorder. Significant linear, quadratic and cubic 
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trends were observed for the onset of any affective disorder. By definition, all BD subjects had 
developed an affective disorder. Figure 1 (B) shows a significant difference between the AR, control 
and BD groups in the onset of any lifetime anxiety disorder. Compared to controls, the AR group was 
more likely to have an onset of any anxiety disorder (HR= 2.76, 95% CI: 1.36–5.59), with the BD 
group showing an even greater ratio (HR= 6.35, 95% CI: 3.02–13.36).  No differences were found 
between the AR and BD groups in the onset of lifetime behavioural disorders. No subjects in the 
control group had a diagnosis of a behavioural disorder. There was a significant difference in the 
onset of lifetime SUDs between the BD and control groups (HR= 5.29, 95% CI: 1.97–14.25, p<.01), 
but there were no significant differences between the AR and control groups. When considering the 
AR group with only parent probands, the levels of significance were the same as for those with 
parent or sibling probands. 
[INSERT FIGURE 1 ABOUT HERE] 
Within group analyses were conducted to test whether prior onset of an anxiety disorder, 
SUD or behavioural disorder increased risk for the later onset of affective disorders. Within the 
control group, prior onset of an anxiety disorder or a SUD was not associated with the onset of any 
affective disorder (note that there were no behavioural disorders in this group). Similarly, within the 
AR group alone, prior onset of an anxiety disorder, SUD or behavioural disorder was not associated 
with the later onset of any affective disorder. Within the BD group alone, prior onset of a 
behavioural disorder was associated with the later onset of an affective disorder (HR= 0.87, 95% CI: 
0.70-0.97, p<.01), but prior onset of an anxiety disorder or SUD was not.  
Analyses as above were also conducted for only those diagnosed with BD who had a family 
history of BD (n=27); similar results were obtained.  
Discussion  
The focus of this study was on clarifying the clinical features that precede the onset of BD, by 
examining, first, rates of clinical features in the AR group compared to controls, and second, clinical 
features that predicted later onset of affective disorders in the BD group.  
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 First, this study extends previous reports in demonstrating that young subjects at high 
genetic risk for BD were also at significantly increased risk for developing a broad range of 
psychopathology (Birmaher et al., 2009; Duffy et al., 2010; Duffy et al., 2014; Hillegers et al., 2005; 
Leopold et al., 2014; Nurnberger et al., 2011; Vandeleur et al., 2012; Wals et al., 2001; Whalley et al., 
2011).  Specifically, we found that AR subjects were more likely to develop depressive, anxiety and 
behavioural disorders compared to controls.  Furthermore, these subjects also had a three-fold 
greater risk for developing at least two lifetime diagnoses.  However, rates of SUDs were not 
increased. There were no substantial differences between AR subjects with a parent or sibling 
proband and those with only a parent proband. 
We also found that those with established BD had a greater risk for developing a range of 
psychopathology than either AR or control subjects.  Those with BD were eight times more likely to 
have two or more lifetime disorders than AR subjects, with a more than three-fold increased risk of 
having an anxiety disorder and an almost five-fold increased risk of a SUD (though no significant 
difference in the rates of behavioural disorders). In the only other comparison of lifetime rates of 
comorbid disorders in AR and BD subjects of which we are aware, Goldstein et al (2010) found 
higher rates of anxiety and behavioural disorders in their BD group. Our finding of an intermediate 
rate of psychopathology in the AR group - between the BD and control samples - is consistent with 
this being a heterogeneous population, i.e. only a proportion will go on to later develop BD.  
           One of the issues of major contemporary interest in such AR populations is whether prior 
symptomatology increases the later risk for developing a major affective disorder such as depression 
or BD. Both Nurnberger et al (2011) and Duffy et al (2010) have demonstrated that prior anxiety 
disorders increase the likelihood of future major affective disorders in AR samples. Furthermore, 
Nurnberger et al (2011) have also shown that prior behavioural disorders also increase the risk for 
the later development of major affective illness. Notably, Nurnberger et al (2011) did not find such 
associations in their control group, suggesting that this relationship was specific to the AR sample.  
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Whilst we did not find that such prior conditions increased the risk of later depression in our 
at-risk sample we did find in our BD group that prior behavioural disorders predicted later onset of 
affective illness. These associations were not present within our control sample. We interpret this 
finding as a partial replication of the Nurnberger et al (2011) report concerning prior behavioural 
disorders as a risk factor to later affective conditions. It is difficult to reconcile our finding of a lack of 
predictive capacity of prior anxiety disorders with the reports of Nurnberger et al (2011) and Duffy et 
al (2014). As our sample was smaller than both of these studies, it is possible that our negative result 
was due to insufficient statistical power. Other possible explanations for this lack of association 
between preceding anxiety disorders and subsequent affective disorders may be the relatively young 
age of the AR cohort and the cross-sectional design utilising retrospectively collected data. 
One of the unexpected, but nonetheless intriguing, findings was the impact of the current 
parental relationship upon the psychopathology of the young person – irrespective of the diagnostic 
grouping. The odds of an affective disorder were 4.9 times greater for those living in a single parent 
home than for those living with both biological parents.  This is consistent with a finding from a Swiss 
high-risk study (Vandeleur et al., 2012) which found that lower rates of affective disorders in AR 
offspring were associated with living with both biological parents, and is in line with the broader 
literature on the increased rate of later mental illness in children who were exposed to parental 
marital disruption during their developmental years (Gilman et al., 2003; Strohschein et al., 2005; 
Cherlin et al., 1998).  However, as our findings are cross-sectional we cannot exclude the alternative 
possibility that the disruption in the parental relationships may be due to the impact of severe 
affective illness in these families. Nonetheless, our findings highlight the importance of considering 
environmental (in this case, stability of the parental relationship) as well as genetic factors in the 
causative pathways towards the development of major affective illness in these high-risk families.   
Limitations 
First, as few participants met diagnostic criteria for some specific behavioural or anxiety disorders, 
such as ADHD, it was not possible to conduct predictive analyses examining particular disorders. 
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Second, as this was a cross-sectional study, information on the onset of disorders was based on 
retrospective recall with its inherent limitations. It should be noted here that this is also a limitation 
for most of the other studies that have addressed this issue.  As the current study is following 
subjects prospectively, future reports will detail prospectively-obtained symptomatic and diagnostic 
data. Third, retrospective data was obtained from individuals of different ages with varying 
durations of illness history. We attempted to control for this by covarying for current age, though we 
accept the limitations of this. Fourth, the effect of the parental relationship was based on the 
current marital status, not on the status at the time of onset of the psychopathology. Fifth, we were 
not able to determine socio-economic status (SES) from the instruments used for this study, and 
were therefore unable to examine the effect of SES on rates of psychopathology. Sixth, the low rate 
of ADHD in the parents as determined by the DIGS of all groups suggests a limitation of assay 
sensitivity for this diagnosis using this measure. 
Conclusions 
We have demonstrated that those individuals at high genetic risk for developing BD were more likely 
to meet lifetime criteria for depressive, anxiety and behavioural disorders than controls. Though we 
did not replicate other reports that prior anxiety disorders predict later onset of affective disorders, 
the finding in our BD group that prior behavioural disorders predicted later onset of these conditions 
provided a partial replication of the report of Nurnberger et al (2011) in their AR sample. These 
findings suggest the potential for targeted preventive treatment of such prior conditions to reduce 
the later onset of affective disorders in subjects at increased genetic risk for BD.  
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Abbreviations: Exact, Fisher exact test; ADHD, Attention Deficit Hyperactivity Disorder 
Table 1.  Demographic and clinical comparison of at-risk, control and bipolar groups 
 
Control At-risk 
Bipolar 
disorder Statistic p-value 
Pairwise 
Comparison 
(n=110) (n=118) (n=44) 
  Demographic       
Males, no. (%) 49 (44.5) 56 (47.5) 17 (38.6) χ
2 
= 1.015 p= 0.61 - 
Age, mean (SD)
a 
22.5 (3.7) 19.9 (5.7) 24 (4.2) F = 15.66 p<.0001   ABC 
Ethnicity, Caucasian (%)
 
76 (69.1) 117 (99.2) 38 (86.4) χ
2 
= 40.27 p<.0001 ABC 
Years of education, mean (SD)
a
  15.6 (2.4) 12.8 (3.7) 15.5 (2.8) F = 24.33 p<.0001 AB 
Occupation, unemployed and not a 
student (%)  
8 (7.3) 3 (2.5) 9 (20.5) χ
2 
= 18.59 p <.01 BC 
Currently living with at least 1 parent (%) 39 (35.5) 65 (55.1) 20 (58.8) χ
2 
= 19.91 p<.01 AC 
Parental disorders
b 
      
Parent with any bipolar disorder, n. (%)
c
 0 (0) 102 (86.4) 10 (22.7) Exact  p<.0001 ABC 
BDI, n. (%) 0 (0) 67 (69.1) 7 (70) - - - 
BDII, n. (%) 0 (0) 35 (30.9) 3 (30) - - - 
Parent with recurrent major depressive 
disorder, n. (%) 
0 (0) 29 (24.6 ) 19 (43.2) χ
2 
= 47.21 p.< 0001 ABC 
Parent with anxiety disorder, n. (%) 0 (0) 18 (15.3) 8 (18.2) Exact  p.<0001 AC 
Parent with substance disorder, n. (%) 2 (1.8) 30 (25.4) 7 (15.9) χ
2 
= 25.93 p.<0001 AC 
Parent with ADHD, n. (%) 0 (0) 1 (0.8) 0 (0) Exact  p= 1.00 - 
Parent with psychosis, n. (%)
 
 0 (0) 0 (0) 1 (2.3) Exact  p= 0.16                 - 
Both parent, no disorders, n. (%) 106 (96.4) 4 (3.4) 18 (40.9) χ
2 
= 198.32 p.<0001    ABC 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
a 
Welch F statistic was used 
b
 At least one parent has the following disorder 
c 
Remaining 13.6% of At-risk participants have a sibling with bipolar disorder 
A = C versus AR; B = AR versus BD ; C = C versus BD 
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Table 2.  Rates of lifetime disorders in at-risk, control and bipolar disorder groups 
           
Psychiatric Disorders   Control   At-risk   
Bipolar 
disorder 
Statistic p-value 
Pairwise 
Comparison 
  
Age of 
Onset  
(n=110) Age of 
Onset  
(n=118) Age of 
Onset  
(n=44) 
    
Any lifetime affective disorder, n. (%) 22 (3.9) 14 (12.7) 19 (5.6) 35 (29.7) 15 (3.3) 44 (100) Exact p.<0001   ABC 
Any lifetime anxiety disorder, n. (%) 21 (5.6) 11 (10) 18 (6.7) 27 (22.9) 18 (8.6) 23 (52.3) χ 
2 
= 32.31 p.<0001 
 
ABC 
Any lifetime behavioural disorder, n. (%)
a
 22 (3.7) 0 (0) 20 (5.7) 11 (9.3) 24 (5.2) 7 (15.9) Exact p.<0001 
 
AC 
Any substance use disorder, n. (%) 22 (3.9) 6 (5.5) 20 (5.7) 8 (6.8) 22 (5.4) 13 (29.5) χ 
2 
= 22.71 p.<0001 
 
BC 
At least one lifetime diagnosis, n. (%) 
 
27 (24.5) 
 
63 (53.4) 
 
44 (100) Exact p.<0001               ABC 
Two or more lifetime diagnoses, n. (%) 
 
6 (5.5) 
 
21 (17.8) 
 
29 (65.9) Exact p.<0001               ABC 
No disorders, n. (%) 
 
83 (75.5) 
 
55 (46.6) 
 
0 (0) Exact p.<0001              ABC 
At least one psychotropic medication,  
 4 (3.6)  11 (9.3)  33 (75.0) χ 
2 
= 120.07 
p<.0001               BC 
current, n. (%)             
           
a 
Behavioural disorders included: Attention Deficit Hyperactivity Disorder, Conduct Disorder and Antisocial Personality Disorder 
  A = C versus AR; B = AR versus BD ; C = C versus BD 
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Table 3.  Odds ratios and 95% confidence intervals for psychiatric disorders between At-risk, Control and Bipolar groups 
Disorders 
 
At-risk v Control 
 
Bipolar disorder v 
Control 
 
Bipolar disorder v 
At-risk 
 
Any affective disorder 2.6 (1.2-5.6)* - - 
Any anxiety disorder
 
2.7 (1.2-6.3)* 9.7 (3.9-24.2)*** 3.6 (1.6-8.1)** 
Any behavioural disorder
 a 
3.9 (0.9-17.0)
b
 7.9 (1.8-35.0)**  2 (0.6-6.7) 
Any substance use disorder  1.3 (0.5-3.9) 6.2 (2.1-18.3)** 4.7 (1.7-13)** 
At least two lifetime diagnoses  3.2 (1.2-8.5)* 27.9 (9.7-79.8)*** 8.8  (3.7-21)*** 
Adjusting for participant gender, age, ethnicity and home environment (parents) 
a 
Behavioural disorders included: Attention Deficit Hyperactivity Disorder, Conduct Disorder and Antisocial Personality Disorder 
b
 p= 0.073 
*p<0.05; **p<0.01; ***p<0.001 
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Figure 1 Onset of disorders in at-risk, control and bipolar disorder groups. (A) Affective disorders; 
(B) Anxiety disorders 
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• Young people at high genetic risk for bipolar disorder had significantly increased lifetime risks for 
depressive, anxiety and behavioural disorders compared to controls.    
• Unlike prior reports, preceding anxiety and behavioural disorders were not found to increase risk 
for later onset of affective disorders in the at-risk sample, perhaps due to limited sample size.  
• Preceding behavioural disorders did predict later onset of affective disorders in the bipolar 
disorder sample.  
• The findings suggest the possibility of therapeutic targeting for depressive, anxiety and 
behavioural disorders in those at high genetic risk for bipolar disorder.  
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